{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,28]],"date-time":"2025-08-28T12:40:45Z","timestamp":1756384845139,"version":"3.41.2"},"reference-count":47,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2021,4,8]],"date-time":"2021-04-08T00:00:00Z","timestamp":1617840000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100014677","name":"Universitatea de Medicin\u0103, Farmacie, \u0218tiin\u021be \u0219i Tehnologie \u201cGeorge Emil Palade\u201d Din T\u00e2rgu Mure\u0219","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100014677","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pharmacol."],"abstract":"<jats:p><jats:bold>Background:<\/jats:bold> The complex interactions that exist between the pacemaker current, <jats:italic>I<\/jats:italic><jats:sub>f<\/jats:sub>, and the parasympathetic nervous system could significantly influence the course of patients undergoing chronic therapy with the <jats:italic>I<\/jats:italic><jats:sub>f<\/jats:sub> blocker ivabradine. We thus aimed to assess the effects of chronic ivabradine therapy on autonomic modulation and on the cardiovascular response to <jats:italic>in situ<\/jats:italic> and <jats:italic>in vitro<\/jats:italic> parasympathetic stimulation. The right atrial expression of HCN genes, encoding proteins for <jats:italic>I<\/jats:italic><jats:sub>f<\/jats:sub>, was also evaluated.<\/jats:p><jats:p><jats:bold>Methods:<\/jats:bold> Sympathetic and parasympathetic heart rate variability parameters and right atrial <jats:italic>HCN<\/jats:italic>(1-4) RNA levels were analyzed in 6 Control and 10 ivabradine-treated male Wistar rats (IVA; 3\u00a0weeks, 10\u00a0mg\/kg\/day). The heart rate (HR) and systolic blood pressure (SBP) responses to <jats:italic>in situ<\/jats:italic> electrical stimulation of the vagus nerve (2\u201320\u00a0Hz) were assessed in 6 additional Control and 10 IVA rats. The spontaneous sinus node discharge rate (SNDR) response to <jats:italic>in vitro<\/jats:italic> cholinergic receptors stimulation using carbamylcholine (10<jats:sup>\u22129<\/jats:sup>\u201310<jats:sup>\u22126<\/jats:sup>\u00a0mol\/L) was also assessed in these later rats.<\/jats:p><jats:p><jats:bold>Results:<\/jats:bold> Ivabradine significantly increased vagal modulation and shifted the sympatho-vagal balance toward vagal dominance. In Control, <jats:italic>in situ<\/jats:italic> vagus nerve stimulation induced progressive decrease in both the SBP (<jats:italic>p<\/jats:italic> = 0.0001) and the HR (<jats:italic>p<\/jats:italic>&amp;lt; 0.0001). Meanwhile, in IVA, vagal stimulation had no effect on the HR (<jats:italic>p<\/jats:italic> = 0.16) and induced a significantly lower drop in SBP (<jats:italic>p<\/jats:italic>&amp;lt; 0.05). IVA also displayed a significantly lower SNDR drop in response to carbamylcholine (<jats:italic>p<\/jats:italic>&amp;lt; 0.01) and significantly higher right atrial <jats:italic>HCN4<\/jats:italic> expression (<jats:italic>p<\/jats:italic> = 0.02).<\/jats:p><jats:p><jats:bold>Conclusion:<\/jats:bold> Chronic ivabradine administration enhanced vagal modulation in healthy rats. In addition, ivabradine reduced the HR response to direct muscarinic receptors stimulation, canceled the cardioinhibitory response and blunted the hemodynamic response to <jats:italic>in situ<\/jats:italic> vagal stimulation. These data bring new insights into the mechanisms of ivabradine-related atrial proarrhythmia and suggest that long-term <jats:italic>I<\/jats:italic><jats:sub>f<\/jats:sub> blockade may protect against excessive bradycardia induced by acute vagal activation.<\/jats:p>","DOI":"10.3389\/fphar.2021.596956","type":"journal-article","created":{"date-parts":[[2021,4,8]],"date-time":"2021-04-08T05:17:08Z","timestamp":1617859028000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":11,"title":["Long-Term Effects of Ivabradine on Cardiac Vagal Parasympathetic Function in Normal Rats"],"prefix":"10.3389","volume":"12","author":[{"given":"Alina","family":"Scridon","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vasile Bogdan","family":"Hala\u0163iu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alkora Ioana","family":"Balan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dan Alexandru","family":"Cozac","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Valeriu","family":"Moldovan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Claudia","family":"B\u0103nescu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marcel","family":"Perian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R\u0103zvan Constantin","family":"\u015eerban","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2021,4,8]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1002\/ejhf.258","article-title":"Twenty-four-hour heart rate lowering with ivabradine in chronic heart failure: insights from the SHIFT Holter substudy","volume":"17","author":"B\u00f6hm","year":"2015","journal-title":"Eur. J. Heart Fail."},{"key":"B2","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1093\/eurheartj\/ehi647","article-title":"A new management of syncope: prospective systematic guideline-based evaluation of patients referred urgently to general hospitals","volume":"27","author":"Brignole","year":"2006","journal-title":"Eur. Heart J."},{"key":"B3","doi-asserted-by":"publisher","first-page":"112S","DOI":"10.1016\/s0895-7061(00)00228-4","article-title":"Autonomic imbalance, hypertension, and cardiovascular risk","volume":"13","author":"Brook","year":"2000","journal-title":"Am. J. Hypertens."},{"key":"B4","doi-asserted-by":"publisher","first-page":"83","DOI":"10.2165\/00126839-200304020-00001","article-title":"Electrophysiological effects of a single intravenous administration of ivabradine (S 16257) in adult patients with normal baseline electrophysiology","volume":"4","author":"Camm","year":"2003","journal-title":"Drugs R. andD"},{"key":"B5","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1016\/j.clinthera.2015.12.018","article-title":"Meta-analysis of ivabradine in patients with stable coronary artery disease with and without left ventricular dysfunction","volume":"38","author":"Cammarano","year":"2016","journal-title":"Clin. Ther."},{"key":"B6","doi-asserted-by":"publisher","first-page":"1323","DOI":"10.1016\/j.jacc.2012.06.031","article-title":"Clinical efficacy of ivabradine in patients with inappropriate sinus tachycardia","volume":"60","author":"Cappato","year":"2012","journal-title":"J. Am. Coll. Cardiol."},{"key":"B7","doi-asserted-by":"publisher","first-page":"1562","DOI":"10.1161\/CIRCULATIONAHA.108.804369","article-title":"Molecular architecture of the human sinus node","volume":"119","author":"Chandler","year":"2009","journal-title":"Circulation"},{"key":"B8","doi-asserted-by":"publisher","first-page":"i9","DOI":"10.1007\/s10286-004-1003-3","article-title":"Epidemiology of reflex syncope","volume":"14","author":"Colman","year":"2004","journal-title":"Clin. Auton. Res."},{"key":"B9","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1161\/CIRCRESAHA.109.208041","article-title":"The role of the funny current in pacemaker activity","volume":"106","author":"DiFrancesco","year":"2010","journal-title":"Circ. Res."},{"key":"B10","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.trsl.2017.03.004","article-title":"Atrial fibrillation is associated with hypermethylation in human left atrium, and treatment with decitabine reduces atrial tachyarrhythmias in spontaneously hypertensive rats","volume":"184","author":"Do\u00f1ate Puertas","year":"2017","journal-title":"Translational Res."},{"key":"B11","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1097\/FJC.0000000000000586","article-title":"Possible ameliorative effect of ivabradine on the autonomic and left ventricular dysfunction induced by doxorubicin in male rats","volume":"72","author":"El-Naggar","year":"2018","journal-title":"J. Cardiovasc. Pharmacol."},{"key":"B12","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/j.jacc.2013.07.096","article-title":"Regional myocardial sympathetic denervation predicts the risk of sudden cardiac arrest in ischemic cardiomyopathy","volume":"63","author":"Fallavollita","year":"2014","journal-title":"J. Am. Coll. Cardiol."},{"key":"B13","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1093\/eurheartj\/ehi115","article-title":"Randomized trial to determine the effect of nebivolol on mortality and cardiovascular hospital admission in elderly patients with heart failure (SENIORS)","volume":"26","author":"Flather","year":"2005","journal-title":"Eur. Heart J."},{"key":"B14","doi-asserted-by":"publisher","first-page":"1974","DOI":"10.1093\/eurheartj\/ehv087","article-title":"The sympathetic\/parasympathetic imbalance in heart failure with reduced ejection fraction","volume":"36","author":"Floras","year":"2015","journal-title":"Eur. Heart J."},{"key":"B15","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1016\/j.jacc.2009.03.061","article-title":"Sympathetic nervous system Activation in human heart failure","volume":"54","author":"Floras","year":"2009","journal-title":"J. Am. Coll. Cardiol."},{"key":"B16","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1007\/s13239-013-0150-x","article-title":"Automatic atrial arrhythmia detection based on RR interval analysis in conscious rats","volume":"4","author":"Gallet","year":"2013","journal-title":"Cardiovasc. Eng. Tech."},{"key":"B17","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1007\/s40256-017-0252-1","article-title":"Ivabradine for the treatment of postural orthostatic tachycardia syndrome: a systematic review","volume":"18","author":"Gee","year":"2018","journal-title":"Am. J. Cardiovasc. Drugs"},{"key":"B18","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1038\/hr.2015.122","article-title":"Effect of selective vagal nerve stimulation on blood pressure, heart rate and respiratory rate in rats under metoprolol medication","volume":"39","author":"Gierthmuehlen","year":"2016","journal-title":"Hypertens. Res."},{"key":"B19","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1016\/j.mehy.2006.05.031","article-title":"The altered homeostatic theory: a hypothesis proposed to be useful in understanding and preventing ischemic heart disease, hypertension, and diabetes\u2014including reducing the risk of age and atherosclerosis","volume":"68","author":"Hellstrom","year":"2007","journal-title":"Med. Hypotheses"},{"key":"B20","doi-asserted-by":"crossref","first-page":"2001","DOI":"10.1016\/S0140-6736(99)04440-2","article-title":"Effect of metoprolol CR\/XL in chronic heart failure: metoprolol CR\/XL randomised intervention trial in congestive heart failure (MERIT-HF)","volume":"353","author":"Hjalmarson","year":"1999","journal-title":"Lancet"},{"key":"B21","doi-asserted-by":"publisher","first-page":"2212","DOI":"10.1016\/j.jacc.2010.01.014","article-title":"Myocardial iodine-123 meta-iodobenzylguanidine imaging and cardiac events in heart failure","volume":"55","author":"Jacobson","year":"2010","journal-title":"J. Am. Coll. Cardiol."},{"key":"B22","doi-asserted-by":"publisher","first-page":"H597","DOI":"10.1152\/ajpheart.00288.2019","article-title":"Intravenous ivabradine augments the dynamic heart rate response to moderate vagal nerve stimulation in anesthetized rats","volume":"317","author":"Kawada","year":"2019","journal-title":"Am. J. Physiology-Heart Circulatory Physiol."},{"key":"B23","doi-asserted-by":"publisher","first-page":"809","DOI":"10.1113\/JP275303","article-title":"HCN4 pacemaker channels attenuate the parasympathetic response and stabilize the spontaneous firing of the sinoatrial node","volume":"596","author":"Kozasa","year":"2018","journal-title":"J. Physiol."},{"key":"B24","doi-asserted-by":"publisher","first-page":"308","DOI":"10.5935\/abc.20140109","article-title":"Ivabradine improves heart rate variability in patients with nonischemic dilated cardiomyopathy","volume":"103","author":"Kurtoglu","year":"2014","journal-title":"Arq Bras Cardiol."},{"key":"B25","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/S0140-6736(98)11181-9","article-title":"The cardiac insufficiency bisoprolol study II (CIBIS-II): a randomised trial","volume":"353","author":"Lechat","year":"1999","journal-title":"Lancet"},{"key":"B26","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1590\/bjpt-rbf.2014.0176","article-title":"Immediate and short-term effects of the combination of dry needling and percutaneous TENS on post-needling soreness in patients with chronic myofascial neck pain","volume":"20","author":"Le\u00f3n-Hern\u00e1ndez","year":"2016","journal-title":"Braz. J. Phys. Ther."},{"key":"B27","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1152\/physiolgenomics.00161.2005","article-title":"Chronic heart rate reduction remodels ion channel transcripts in the mouse sinoatrial node but not in the ventricle","volume":"24","author":"Leoni","year":"2006","journal-title":"Physiol. Genomics"},{"key":"B28","doi-asserted-by":"publisher","first-page":"2292","DOI":"10.12659\/MSM.892505","article-title":"Association between reversal in the expression of hyperpolarization-activated cyclic nucleotide-gated (HCN) channel and age-related atrial fibrillation","volume":"20","author":"Li","year":"2014","journal-title":"Med. Sci. Monit."},{"key":"B29","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1097\/00005344-199810000-00012","article-title":"Relationships between heart rate and heart rate variability: study in conscious rats","volume":"32","author":"Mangin","year":"1998","journal-title":"J. Cardiovasc. Pharmacol."},{"key":"B30","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1159\/000073933","article-title":"A single intravenous dose of ivabradine, a novel if inhibitor, lowers heart rate but does not depress left ventricular function in patients with left ventricular dysfunction","volume":"100","author":"Manz","year":"2003","journal-title":"Cardiology"},{"key":"B31","doi-asserted-by":"publisher","first-page":"1506","DOI":"10.1136\/heartjnl-2014-305482","article-title":"Atrial fibrillation associated with ivabradine treatment: meta-analysis of randomised controlled trials","volume":"100","author":"Martin","year":"2014","journal-title":"Heart"},{"key":"B32","doi-asserted-by":"publisher","first-page":"H435","DOI":"10.1152\/ajpheart.00591.2008","article-title":"Beneficial effects of delayed ivabradine treatment on cardiac anatomical and electrical remodeling in rat severe chronic heart failure","volume":"296","author":"Milliez","year":"2009","journal-title":"Am. J. Physiology-Heart Circulatory Physiol."},{"key":"B33","doi-asserted-by":"publisher","first-page":"2672","DOI":"10.1152\/jappl.1993.74.6.2672","article-title":"Importance of left atrial baroreceptors in the cardiopulmonary baroreflex of normal humans","volume":"74","author":"Oren","year":"1993","journal-title":"J. Appl. Physiol."},{"key":"B34","doi-asserted-by":"publisher","first-page":"903","DOI":"10.1038\/nrd3576","article-title":"Exploring HCN channels as novel drug targets","volume":"10","author":"Postea","year":"2011","journal-title":"Nat. Rev. Drug Discov."},{"key":"B35","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1124\/pr.117.014035","article-title":"The hyperpolarization-activated cyclic nucleotide-gated channels: from biophysics to pharmacology of a unique family of ion channels","volume":"69","author":"Sartiani","year":"2017","journal-title":"Pharmacol. Rev."},{"key":"B36","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1159\/000095430","article-title":"Novel if current inhibitor ivabradine: safety considerations","volume":"43","author":"Savelieva","year":"2006","journal-title":"Adv. Cardiol."},{"key":"B37","doi-asserted-by":"publisher","first-page":"H386","DOI":"10.1152\/ajpheart.00004.2012","article-title":"Unprovoked atrial tachyarrhythmias in aging spontaneously hypertensive rats: the role of the autonomic nervous system","volume":"303","author":"Scridon","year":"2012","journal-title":"Am. J. Physiology-Heart Circulatory Physiol."},{"key":"B38","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1515\/rrlm-2015-0028","article-title":"Wistar rats with long-term streptozotocin-induced type 1 diabetes mellitus replicate the most relevant clinical, biochemical, and hematologic features of human diabetes\/Sobolanii Wistar cu diabet zaharat tip 1 indus cu streptozotocina reproduc cele mai relevante caracteristici clinice, biochimice si hematologice ale diabetului uman","volume":"23","author":"Scridon","year":"2015","journal-title":"Rev. Romana Med. Lab."},{"key":"B39","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.acvd.2017.11.001","article-title":"Atrial fibrillation: neurogenic or myogenic?","volume":"111","author":"Scridon","year":"2018","journal-title":"Arch. Cardiovasc. Dis."},{"key":"B40","doi-asserted-by":"publisher","first-page":"305","DOI":"10.3389\/fphys.2016.00305","article-title":"Chronic treatment with ivabradine does not affect cardiovascular autonomic control in rats","volume":"7","author":"Silva","year":"2016","journal-title":"Front. Physiol."},{"key":"B41","doi-asserted-by":"publisher","first-page":"1457","DOI":"10.1111\/j.1476-5381.2011.01627.x","article-title":"Long-term treatment with ivabradine in post-myocardial infarcted rats counteracts f-channel overexpression","volume":"165","author":"Suffredini","year":"2012","journal-title":"Br. J. Pharmacol."},{"key":"B42","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1093\/europace\/eut226","article-title":"Ivabradine in treatment of sinus tachycardia mediated vasovagal syncope","volume":"16","author":"Sutton","year":"2014","journal-title":"Europace"},{"key":"B43","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1016\/S0140-6736(10)61198-1","article-title":"Ivabradine and outcomes in chronic heart failure (SHIFT): a randomised placebo-controlled study","volume":"376","author":"Swedberg","year":"2010","journal-title":"The Lancet"},{"key":"B44","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1016\/j.jacc.2020.12.029","article-title":"Randomized trial of ivabradine in patients with hyperadrenergic postural orthostatic tachycardia syndrome","volume":"77","author":"Taub","year":"2021","journal-title":"J. Am. Coll. Cardiol."},{"key":"B45","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1007\/s00380-016-0922-y","article-title":"Acute ivabradine treatment reduces heart rate without increasing atrial fibrillation inducibility irrespective of underlying vagal activity in dogs","volume":"32","author":"Uemura","year":"2017","journal-title":"Heart Vessels"},{"key":"B46","doi-asserted-by":"publisher","first-page":"1361","DOI":"10.1002\/ejhf.921","article-title":"The autonomic nervous system as a therapeutic target in heart failure: a scientific position statement from the Translational Research Committee of the Heart Failure Association of the European Society of Cardiology","volume":"19","author":"van Bilsen","year":"2017","journal-title":"Eur. J. Heart Fail."},{"key":"B47","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1111\/jce.13772","article-title":"Long\u2010term treatment with ivabradine in transgenic atrial fibrillation mice counteracts hyperpolarization\u2010activated cyclic nucleotide gated channel overexpression","volume":"30","author":"Wang","year":"2019","journal-title":"J. Cardiovasc. Electrophysiol."}],"container-title":["Frontiers in Pharmacology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2021.596956\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,4,8]],"date-time":"2021-04-08T05:17:13Z","timestamp":1617859033000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2021.596956\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4,8]]},"references-count":47,"alternative-id":["10.3389\/fphar.2021.596956"],"URL":"https:\/\/doi.org\/10.3389\/fphar.2021.596956","relation":{},"ISSN":["1663-9812"],"issn-type":[{"type":"electronic","value":"1663-9812"}],"subject":[],"published":{"date-parts":[[2021,4,8]]},"article-number":"596956"}}